Nothing Special   »   [go: up one dir, main page]

ATE484520T1 - Antitumorheilmittel, medikament, zusammensetzung und verwendung davon - Google Patents

Antitumorheilmittel, medikament, zusammensetzung und verwendung davon

Info

Publication number
ATE484520T1
ATE484520T1 AT07290440T AT07290440T ATE484520T1 AT E484520 T1 ATE484520 T1 AT E484520T1 AT 07290440 T AT07290440 T AT 07290440T AT 07290440 T AT07290440 T AT 07290440T AT E484520 T1 ATE484520 T1 AT E484520T1
Authority
AT
Austria
Prior art keywords
medication
composition
antitumor medicine
seq
acid sequence
Prior art date
Application number
AT07290440T
Other languages
English (en)
Inventor
Sylvie Colin
Salman Al-Mahmood
Original Assignee
Gene Signal Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Signal Int Sa filed Critical Gene Signal Int Sa
Application granted granted Critical
Publication of ATE484520T1 publication Critical patent/ATE484520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07290440T 2007-04-11 2007-04-11 Antitumorheilmittel, medikament, zusammensetzung und verwendung davon ATE484520T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07290440A EP1980571B1 (de) 2007-04-11 2007-04-11 Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon

Publications (1)

Publication Number Publication Date
ATE484520T1 true ATE484520T1 (de) 2010-10-15

Family

ID=38462232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07290440T ATE484520T1 (de) 2007-04-11 2007-04-11 Antitumorheilmittel, medikament, zusammensetzung und verwendung davon

Country Status (4)

Country Link
EP (1) EP1980571B1 (de)
AT (1) ATE484520T1 (de)
DE (1) DE602007009797D1 (de)
HK (1) HK1123813A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653445B1 (en) * 1997-01-21 2003-11-25 Human Genome Sciences, Inc. Human CCV polypeptides
JP2004512832A (ja) * 2000-09-01 2004-04-30 バイオアクタ・リミテッド 抗−血管新生ペプチド
FR2836687A1 (fr) * 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
AU2003288918A1 (en) * 2002-10-04 2004-05-04 Van Andel Research Institute Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers
JP2007523099A (ja) * 2004-02-20 2007-08-16 ノボ　ノルディスク　アクティーゼルスカブ 組み合わせ療法

Also Published As

Publication number Publication date
HK1123813A1 (en) 2009-06-26
EP1980571A1 (de) 2008-10-15
DE602007009797D1 (de) 2010-11-25
EP1980571B1 (de) 2010-10-13

Similar Documents

Publication Publication Date Title
MX2008009493A (es) Peptido novedoso y uso del mismo.
IN2012DN02981A (de)
NZ595063A (en) Polypeptides from neisseria meningitidis
BR112014007069A2 (pt) proteínas de fusão para o tratamento de distúrbios metabólicos
NZ627111A (en) Variants of activin iib receptor polypeptides and uses thereof
PE20120358A1 (es) Mutantes fgf21 y usos de los mismos
MX2009004147A (es) Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1.
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
EP2532365A4 (de) Pharmazeutische zusammensetzung zur behandlung und/oder prävention von krebs
NZ600690A (en) Fkbp-l and uses thereof
ES2668967T3 (es) Inmunógenos de Escherichia coli con solubilidad mejorada
AR072009A1 (es) Mutantes del factor de crecimiento de los fibroblastos fgf21 y usos de los mismos
PE20110310A1 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
CO6491059A2 (es) Diferenciacion de las celulas madre mesenquimales
BRPI0811320A2 (pt) Surfactantes reconstituídos com propriedades melhoradas
ATE449790T1 (de) Rekombinante gelatinepartikel für die zelladhäsion
ATE509096T1 (de) Von sparc abgeleitetes krebsabstossungsantigenpeptid und pharmazeutikum, das dieses enthält
RU2015118580A (ru) НОВЫЙ ВЫСОКО ФУНКЦИОНАЛЬНЫЙ ФЕРМЕНТ, ИМЕЮЩИЙ МОДИФИЦИРОВАННУЮ СУБСТРАТНУЮ СПЕЦИФИЧНОСТЬ β-ГЕКСОЗАМИНИДАЗЫ ЧЕЛОВЕКА И ПРОЯВЛЯЮЩИЙ УСТОЙЧИВОСТЬ К ПРОТЕАЗЕ
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
NZ703514A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
NZ708091A (en) Stabilized insulin-like growth factor polypeptides
NZ594268A (en) Grass peptides for vaccine
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties